A combination therapy of continuous superselective intraarterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma: A phase I study

Cancer

Volumn 89, Issue 10, 2000, Pages 2099-2105

  Fuwa, Nobukazu ^a   Ito, Yoshiyuki ^a   Matsumoto, Akira ^a   Kamata, Minoru ^a   Kodaira, Takesi ^a   Furutani, Kazuhisa ^a   Sasaoka, Masahiro ^a   Kimura, Yasuo ^a   Morita, Kozo ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Carboplatin; Head and neck carcinoma; Intraarterial chemotherapy; Radiation therapy

Indexed keywords

CARBOPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INFUSION; DRUG RESPONSE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MALE; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TONGUE CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARBOPLATIN; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034669613     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20001115)89:10<2099::AID-CNCR10>3.0.CO;2-4     Document Type: Article

References (25)

1. Fractionated intra-arterial cancer chemotherapy with methyl bis amine hydrochloride: A preliminary report
2. Antimetabolite-metabolite combination cancer chemotherapy: Effects of intra-arterial methotrexate-intramuscular citrovorum factor therapy in human cancer
3. Perfusion and infusion techniques in cancer chemotherapy
4. Induction intra-arterial cisplatin and bleomycin in head and neck cancer
5. Evaluation of high-dose cisplatin and 5-FU infusion as initial therapy in advanced head and neck cancer
6. A phase randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck
7. Dose: A critical factor in cancer chemotherapy
8. Advanced squamous cell carcinoma of the maxillary sinus. Results of combined regional infusion chemotherapy, radiation therapy and surgery
9. Intraarterial chemotherapy for head and neck cancer. Part 2: Clinical experience
10. Intra-arterial continuous infusion of cis-diamminedichloroplatinum in untreated head and neck cancer patients
11. An organ-preserving selective arterial chemotherapy strategy for head and neck cancer
12. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: The Memphis experience
13. Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer
14. Superselective intraarterial chemotherapy in combination with irradiation: Preliminary report
15. Non-parametric estimations from incomplete observations
16. Examining survival data
17. Overview of carboplatin: Replacing, complementing, and extending the therapeutic horizons of cisplatin
18. Carboplatin as a potentiator of radiation therapy
19. Evaluation of mouse lip mucosa reactions after combinations of cis-diammine-1,1-cyclobutanedicarboxylate platinum (II) (CB-DCA) and irradiation: Single and fractionated treatments
20. Carboplatin: The experience in head and neck cancer
21. Intraarterial perfusion therapy with a reservoir for head and neck cancer
22. Pharmocokinetics and dosage reduction of cis-diammine (1,1-cyclobutanedicarboxylate) platinum in patients with impaired renal function
23. Carboplatin dosage: Prospective evaluation of a simple formula based on renal function